phosphatidylcholines has been researched along with diphenylcyclopropenone in 1 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (diphenylcyclopropenone) | Trials (diphenylcyclopropenone) | Recent Studies (post-2010) (diphenylcyclopropenone) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 333 | 50 | 139 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Suwayeh, SA; Fang, JY; Leu, YL; Lin, YK; Shen, FM | 1 |
1 other study(ies) available for phosphatidylcholines and diphenylcyclopropenone
| Article | Year |
|---|---|
Squalene-containing nanostructured lipid carriers promote percutaneous absorption and hair follicle targeting of diphencyprone for treating alopecia areata.
Topics: Alopecia Areata; Animals; Cyclopropanes; Delayed-Action Preparations; Drug Delivery Systems; Female; Hair Follicle; Keratinocytes; Mice; Mice, Nude; Nanostructures; Particle Size; Phosphatidylcholines; Skin; Skin Absorption; Squalene; Surface-Active Agents | 2013 |